Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

RMP-7 advances to phase I/II in Europe

April 26, 1996

SIBIA, Ciba-Geigy extend drug discovery agreement

April 26, 1996

Roche licenses access to LIFESEQ database

April 26, 1996

SIBIA, Salk Institute expand agreement for NAChRs

April 26, 1996

GS-2888, permeation enhancer reported by Gilead, Glaxo Wellcome

April 19, 1996

Signal, Tanabe Seiyaku to collaborate on drug discovery

April 19, 1996

Pharmacopeia will collaborate with Daiichi for drug discovery

April 12, 1996

RMP-7 phase II trials initiated

April 12, 1996

Sequana, Aurora establish drug discovery collaboration

April 12, 1996

Organogenesis to develop treatments based on oral mucosa

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...